Clinical Trial Update: Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin degludec/insulin aspart twice daily versus biphasic insulin aspart twice daily in adults with type 2 diabetes around Ramadan, co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart
• insulin degludec/insulin aspart (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-09-11